In vitro assessment of a novel polyrotaxane-based drug delivery system integrated with a cell-penetrating peptide
about
Artificial Molecular MachinesSecond generation specific-enzyme-activated rotaxane propeptides.Nose-to-brain delivery of macromolecules mediated by cell-penetrating peptidesCyclodextrin-based supramolecular systems for drug delivery: recent progress and future perspectiveCell-penetrating peptides: achievements and challenges in application for cancer treatment.Polyrotaxanes for applications in life science and biotechnology.Threaded macromolecules as a versatile framework for biomaterials.Immobilized thermolysin for highly efficient production of low-molecular-weight protamine--an attractive cell-penetrating peptide for macromolecular drug delivery applications.Drug delivery by supramolecular design.Efficient pDNA Delivery Using Cationic 2-Hydroxypropyl-β-Cyclodextrin Pluronic-Based Polyrotaxanes.Enzymatically Biodegradable Polyrotaxane-Deferoxamine Conjugates for Iron Chelation.Preparation, characterization, and antitumor activity of paclitaxel-loaded folic acid modified and TAT peptide conjugated PEGylated polymeric liposomes.Reduction of doxorubicin resistance in P-glycoprotein overexpressing cells by hybrid cell-penetrating and drug-binding peptide.Toward an optimized treatment of intracellular bacterial infections: input of nanoparticulate drug delivery systems.Cationic α-cyclodextrin:poly(ethylene glycol) polyrotaxanes for siRNA delivery.Multi-armed cationic cyclodextrin:poly(ethylene glycol) polyrotaxanes as efficient gene silencing vectors.Hydrophobic pharmaceuticals mediated self-assembly of beta-cyclodextrin containing hydrophilic copolymers: novel chemical responsive nano-vehicles for drug delivery.Targeting of Cancer Cells Using Quantum Dot-Polypeptide Hybrid Assemblies that Function as Molecular Imaging Agents and Carrier Systems.Improved Protein Toxin Delivery Based on ATTEMPTS Systems.Self-assembling polyrotaxanes: drug carriers for anticancer drugs?A mechanically interlocked molecular system programmed for the delivery of an anticancer drug† †Electronic supplementary information (ESI): Experimental conditions and procedures, syntheses and compounds characterizations (1H, 13C and 2D NMR spectroA mechanically interlocked molecular system programmed for the delivery of an anticancer drug.Transport of macrocyclic compounds across phospholipid bilayers by umbrella-rotaxanes.Construction and Degradation of Polyrotaxane MultilayersPolyrotaxane/gold nanoparticle hybrid nanomaterials as anticancer drug delivery systems
P2860
Q26783064-932FBD16-DD09-42FE-BCC2-AFAFBAF46079Q34121390-E6071C47-A38A-4150-AA35-A58987F6FB0DQ37110643-0F98D536-F3E8-4BB0-A3AC-4180CBB7A8E5Q37454370-2FDDADBE-5BC6-455D-A511-3F7CDE76CAE6Q37594526-A505D8E3-751E-4156-BBAD-C79FF6F8B06EQ37848225-811625EB-5FE9-4E49-8BDC-D18482600ED2Q38230940-0BBE065A-ACDD-47E0-B3A5-B972D7D064F3Q38469048-BE208478-E6F0-488B-A14E-9F4D4936FFFAQ38638945-06296EF1-8F4B-4E57-A89C-FCEAFF3C5B8CQ38844970-71457E24-1F36-43FB-9C00-9865A57488ECQ39395748-1DE3E026-99AF-4834-AA07-0C6BEC7D1F43Q39672732-9D0FE907-D39D-430F-ACE4-18648BB59B22Q39750027-A87F18BB-092E-4265-B52D-42F59EB24788Q40974806-3213CCEF-F645-4BD0-929F-CCE36912A159Q41813002-CAE4BDC8-F2B9-4FC3-BFEC-4153A7CCFB13Q42031723-34389E48-2A53-45DC-A45D-74D391AB2002Q42158141-9195D8B1-BFA4-43E0-BF0F-E82A7FDD92F4Q43175543-4BB53126-DE2A-4C6D-A49C-3D195F933102Q46409297-2D0E36C7-A1CA-4B9D-8E80-2FEF5C137DC1Q46496183-8F84F8F3-2072-4F3B-9AB4-7BACCEE1DD9DQ47141838-D8824EEF-E001-4899-9E00-270E0196DD58Q47193915-46A0C5C4-77D9-48B7-BC59-96AC6BA49F83Q51794098-589676E6-3658-42F8-9B2E-BEDAB1E17779Q57645142-D1AA5456-6AA1-4D11-A061-6E46C438B23DQ57967187-5CFB68E1-55E4-438E-BFE4-4F2CAF9455BC
P2860
In vitro assessment of a novel polyrotaxane-based drug delivery system integrated with a cell-penetrating peptide
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
In vitro assessment of a novel ...... ith a cell-penetrating peptide
@ast
In vitro assessment of a novel ...... ith a cell-penetrating peptide
@en
type
label
In vitro assessment of a novel ...... ith a cell-penetrating peptide
@ast
In vitro assessment of a novel ...... ith a cell-penetrating peptide
@en
prefLabel
In vitro assessment of a novel ...... ith a cell-penetrating peptide
@ast
In vitro assessment of a novel ...... ith a cell-penetrating peptide
@en
P2093
P2860
P1476
In vitro assessment of a novel ...... ith a cell-penetrating peptide
@en
P2093
Cheol Moon
Victor C Yang
Won Kyu Lee
Yoon Jeong Park
Young Min Kwon
P2860
P356
10.1016/J.JCONREL.2007.08.029
P407
P577
2007-09-05T00:00:00Z